Specialty Pharma Journal Specialty, Precision & Technology

KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, and …

Basel, August 4, 2020 — Novartis today announced positive results from the Phase II ELARA trial …

CULVER CITY, Calif.–(BUSINESS WIRE)–ImmunityBio, Inc. a privately-held, clinical-stage immunotherapy company, today announced positive preclinical results …

CARLSBAD, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world …

RESEARCH TRIANGLE PARK, N.C., Aug. 03, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that …

NEWARK, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY) today announced …

PLANEGG, Germany & MUNICH & WILMINGTON, Del.–(BUSINESS WIRE)–MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & …

/PRNewswire/ — Varian (NYSE: VAR) today announced that it has entered into a definitive agreement …

NEW YORK, Aug. 2, 2020 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company …

STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) a …

DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced positive topline data from two clinical trials …

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …

HORSHAM, Pa., July 30, 2020  — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the …

REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced …

WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s TAGRISSO® (osimertinib) has been granted Breakthrough Therapy Designation (BTD) in the US for the …